There Is A Quest For Clarity Surrounding Edwards Lifesciences Corp (NYSE: EW) Volatility

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Edwards Lifesciences Corp is $56.71B. A total of 2.73 million shares were traded on the day, compared to an average of 4.07M shares.

In the most recent transaction, Ullem Scott B. sold 7,255 shares of EW for 94.89 per share on Apr 01 ’24. After the transaction, the CVP, Chief Financial Officer now owns 19,074 company shares. In a previous transaction on Mar 13 ’24, BOBO DONALD E JR sold 14,500 shares at 91.01 per share. EW shares that CVP,Strategy/Corp Development owns now total 39,503.

Among the insiders who sold shares, Lemercier Jean-Luc M disposed of 14,400 shares on Mar 11 ’24 at a per-share price of $91.68. This resulted in the CVP, EMEACLA and JAPAC holding 173,584 shares of EW after the transaction. In another insider transaction, Lippis Daniel J. sold 1,715 shares at $90.98 per share on Mar 07 ’24. Company shares held by the CVP, JAPAC now total 17,213.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, EW has a high of $96.12 and a low of $60.57.

As of this writing, EW has an earnings estimate of $0.64 per share for the current quarter. EPS was calculated based on a consensus of 24 estimates, with a high estimate of $0.66 per share and a lower estimate of $0.63.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EW’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $690.30M in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $11.06, while its Total Shareholder’s Equity was $5.84B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Buy with a score of 3.84.

Most Popular

Related Posts